First Ever Clinical Trials for Managing Takotsubo (Broken Heart Syndrome)
The media in this post is not displayed to visitors. To view it, please go to the original post.
The first ever clinical trial of medication for the long-term management of the condition commonly known as broken heart syndrome is now underway. The seven-year long study, funded by the National Institute for Health and Care Research (NIHR), will involve scientists and clinicians from Aberdeen, Glasgow, Edinburgh, Leeds, Leicester, Belfast and almost 1,000 takotsubo patients from 40 hospitals across the country. Takotsubo cardiomyopathy, sometimes called broken heart syndrome, affects more than 5,000 people in the UK each year […]
